Pfizer begins late-stage trial of COVID-19 vaccine candidate
Tuesday, July 28, 2020 - 01:00
in Health & Medicine
U.S. pharmaceutical Pfizer and German biotech company BioNTech said they have started a late-stage human study of their coronavirus vaccine candidate.